C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients

S. L. Lewis, D. E. Van Epps, D. E. Chenoweth

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Chronic renal failure patients have an increased risk for infection which may partially be due to altered chemotactic ability of their white blood cells. This study was designed to evaluate chemotactic factor and Fc receptor expression on neutrophils (PMN) and monocytes from chronic renal failure patients on hemodialysis (HD) or continuous ambulatory peritoneal dialysis (CAPD). Analysis of these receptors was performed using flow cytometry and fluorescent chemotactic factors (C5a, f-Met-Leu-Phe-Lys [fMLPL] and casein) and heat-aggregated human IgG. Peripheral blood PMN and monocytes obtained from 14 HD patients (in the predialysis period) and 14 CAPD patients were analyzed for their ability to bind each of the fluoresceinated ligands. PMN and monocytes from both patient groups had a significant reduction in their ability to bind C5a. The average percentage (± s.e.m.) of PMN that bound C5a was 93.9 ± 1.1 for the controls, 72.9 ± 3.8 for HD patients, and 79.3 ± 4.0 for CAPD patients. Similar results were obtained with monocytes with 69.7 ± 1.9% for controls, 54.6 ± 4.5% for HD patients, and 31.0 ± 4.5% for CAPD patients. These differences in C5a binding were also reflected in the average intensity of fluorescence. There was no significant difference in the percentage or fluorescence intensity of PMN or monocytes that bound casein or aggregated IgG when either group of dialysis patients was compared to the control values. Binding of fMLPL by PMN and monocytes from the HD patients and PMN from the CAPD patients were similar to control values but the binding of fMLPL by monocytes from CAPD patients was significantly suppressed (p < 0.03). Both HD and CAPD patients had elevated levels of plasma C3a indicating chronic complement activation. These results demonstrate decreased C5a receptor availability on PMN and monocyte in both patient populations which may contribute to these patients' increased risk to infection by reducing the ability of these cells to respond to C5a generated at a site of infection.

Original languageEnglish (US)
Pages (from-to)37-44
Number of pages8
JournalClinical Nephrology
Volume26
Issue number1
StatePublished - 1986
Externally publishedYes

Fingerprint

Anaphylatoxin C5a Receptor
Peritoneal Dialysis
Renal Dialysis
Monocytes
Neutrophils
Continuous Ambulatory Peritoneal Dialysis
Chemotactic Factors
Caseins
Chronic Kidney Failure
Immunoglobulin G
Infection
Fluorescence

ASJC Scopus subject areas

  • Nephrology

Cite this

C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients. / Lewis, S. L.; Van Epps, D. E.; Chenoweth, D. E.

In: Clinical Nephrology, Vol. 26, No. 1, 1986, p. 37-44.

Research output: Contribution to journalArticle

Lewis, S. L. ; Van Epps, D. E. ; Chenoweth, D. E. / C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients. In: Clinical Nephrology. 1986 ; Vol. 26, No. 1. pp. 37-44.
@article{811a2cda4a2d41f388cb33a52ae5c715,
title = "C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients",
abstract = "Chronic renal failure patients have an increased risk for infection which may partially be due to altered chemotactic ability of their white blood cells. This study was designed to evaluate chemotactic factor and Fc receptor expression on neutrophils (PMN) and monocytes from chronic renal failure patients on hemodialysis (HD) or continuous ambulatory peritoneal dialysis (CAPD). Analysis of these receptors was performed using flow cytometry and fluorescent chemotactic factors (C5a, f-Met-Leu-Phe-Lys [fMLPL] and casein) and heat-aggregated human IgG. Peripheral blood PMN and monocytes obtained from 14 HD patients (in the predialysis period) and 14 CAPD patients were analyzed for their ability to bind each of the fluoresceinated ligands. PMN and monocytes from both patient groups had a significant reduction in their ability to bind C5a. The average percentage (± s.e.m.) of PMN that bound C5a was 93.9 ± 1.1 for the controls, 72.9 ± 3.8 for HD patients, and 79.3 ± 4.0 for CAPD patients. Similar results were obtained with monocytes with 69.7 ± 1.9{\%} for controls, 54.6 ± 4.5{\%} for HD patients, and 31.0 ± 4.5{\%} for CAPD patients. These differences in C5a binding were also reflected in the average intensity of fluorescence. There was no significant difference in the percentage or fluorescence intensity of PMN or monocytes that bound casein or aggregated IgG when either group of dialysis patients was compared to the control values. Binding of fMLPL by PMN and monocytes from the HD patients and PMN from the CAPD patients were similar to control values but the binding of fMLPL by monocytes from CAPD patients was significantly suppressed (p < 0.03). Both HD and CAPD patients had elevated levels of plasma C3a indicating chronic complement activation. These results demonstrate decreased C5a receptor availability on PMN and monocyte in both patient populations which may contribute to these patients' increased risk to infection by reducing the ability of these cells to respond to C5a generated at a site of infection.",
author = "Lewis, {S. L.} and {Van Epps}, {D. E.} and Chenoweth, {D. E.}",
year = "1986",
language = "English (US)",
volume = "26",
pages = "37--44",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "1",

}

TY - JOUR

T1 - C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients

AU - Lewis, S. L.

AU - Van Epps, D. E.

AU - Chenoweth, D. E.

PY - 1986

Y1 - 1986

N2 - Chronic renal failure patients have an increased risk for infection which may partially be due to altered chemotactic ability of their white blood cells. This study was designed to evaluate chemotactic factor and Fc receptor expression on neutrophils (PMN) and monocytes from chronic renal failure patients on hemodialysis (HD) or continuous ambulatory peritoneal dialysis (CAPD). Analysis of these receptors was performed using flow cytometry and fluorescent chemotactic factors (C5a, f-Met-Leu-Phe-Lys [fMLPL] and casein) and heat-aggregated human IgG. Peripheral blood PMN and monocytes obtained from 14 HD patients (in the predialysis period) and 14 CAPD patients were analyzed for their ability to bind each of the fluoresceinated ligands. PMN and monocytes from both patient groups had a significant reduction in their ability to bind C5a. The average percentage (± s.e.m.) of PMN that bound C5a was 93.9 ± 1.1 for the controls, 72.9 ± 3.8 for HD patients, and 79.3 ± 4.0 for CAPD patients. Similar results were obtained with monocytes with 69.7 ± 1.9% for controls, 54.6 ± 4.5% for HD patients, and 31.0 ± 4.5% for CAPD patients. These differences in C5a binding were also reflected in the average intensity of fluorescence. There was no significant difference in the percentage or fluorescence intensity of PMN or monocytes that bound casein or aggregated IgG when either group of dialysis patients was compared to the control values. Binding of fMLPL by PMN and monocytes from the HD patients and PMN from the CAPD patients were similar to control values but the binding of fMLPL by monocytes from CAPD patients was significantly suppressed (p < 0.03). Both HD and CAPD patients had elevated levels of plasma C3a indicating chronic complement activation. These results demonstrate decreased C5a receptor availability on PMN and monocyte in both patient populations which may contribute to these patients' increased risk to infection by reducing the ability of these cells to respond to C5a generated at a site of infection.

AB - Chronic renal failure patients have an increased risk for infection which may partially be due to altered chemotactic ability of their white blood cells. This study was designed to evaluate chemotactic factor and Fc receptor expression on neutrophils (PMN) and monocytes from chronic renal failure patients on hemodialysis (HD) or continuous ambulatory peritoneal dialysis (CAPD). Analysis of these receptors was performed using flow cytometry and fluorescent chemotactic factors (C5a, f-Met-Leu-Phe-Lys [fMLPL] and casein) and heat-aggregated human IgG. Peripheral blood PMN and monocytes obtained from 14 HD patients (in the predialysis period) and 14 CAPD patients were analyzed for their ability to bind each of the fluoresceinated ligands. PMN and monocytes from both patient groups had a significant reduction in their ability to bind C5a. The average percentage (± s.e.m.) of PMN that bound C5a was 93.9 ± 1.1 for the controls, 72.9 ± 3.8 for HD patients, and 79.3 ± 4.0 for CAPD patients. Similar results were obtained with monocytes with 69.7 ± 1.9% for controls, 54.6 ± 4.5% for HD patients, and 31.0 ± 4.5% for CAPD patients. These differences in C5a binding were also reflected in the average intensity of fluorescence. There was no significant difference in the percentage or fluorescence intensity of PMN or monocytes that bound casein or aggregated IgG when either group of dialysis patients was compared to the control values. Binding of fMLPL by PMN and monocytes from the HD patients and PMN from the CAPD patients were similar to control values but the binding of fMLPL by monocytes from CAPD patients was significantly suppressed (p < 0.03). Both HD and CAPD patients had elevated levels of plasma C3a indicating chronic complement activation. These results demonstrate decreased C5a receptor availability on PMN and monocyte in both patient populations which may contribute to these patients' increased risk to infection by reducing the ability of these cells to respond to C5a generated at a site of infection.

UR - http://www.scopus.com/inward/record.url?scp=0022527262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022527262&partnerID=8YFLogxK

M3 - Article

C2 - 3488153

AN - SCOPUS:0022527262

VL - 26

SP - 37

EP - 44

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 1

ER -